Adjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular Degeneration
NCT03744767
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Neovascular Age-related Macular Degeneration
Interventions
DRUG:
Spironolactone 50 MG
Sponsor
Dr Irmela MANTEL